Richard Mitten

Richard Mitten

orcid

Research Focus & Metrics

Academic Career Length

38Years (1989-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 March 2007 in Cellular and Molecular Life Sciences
Verified
Journal Article
Closed access
PDF file
NJNathalie Juge
Nathalie Juge
RMRichard Mitten
Richard Mitten
Maria H TrakaMaria H Traka
Maria H Traka

22 September 2009 in Molecular Nutrition & Food Research
Verified
Journal Article
Closed access
PDF file
RVRuud Verkerk
Ruud Verkerk
MSMonika Schreiner
Monika Schreiner
AKAngelika Krumbein
Angelika Krumbein
ECEwa Ciska
Ewa Ciska
BHBirgit Holst
Birgit Holst
MDMatthijs Dekker
Matthijs Dekker

2 March 2015 in Nature Genetics
Verified
Journal Article
Open access
PDF file
TGthe ICGC Prostate Group
the ICGC Prostate Group
CCColin S Cooper
Colin S Cooper
RERosalind Eeles
Rosalind Eeles
DWDavid Wedge
David Wedge
PLPeter Van Loo
Peter Van Loo
DNDavid E Neal
David E Neal
Colin Cooper and colleagues report genome-wide sequences of multiple samples of multifocal cancer and morphologically normal tissue from the prostates of three men. They found high levels of mutations in morphologically normal tissue distant from the cancer, consistent with field effects. Genome-wide DNA sequencing was used to decrypt the phylogeny of multiple samples from distinct areas of cancer and morphologically normal tissue taken from the prostates of three men. Mutations were present at high levels in morphologically normal tissue distant from the cancer, reflecting clonal expansions, and the underlying mutational processes at work in morphologically normal tissue were also at work in cancer. Our observations demonstrate the existence of ongoing abnormal mutational processes, consistent with field effects, underlying carcinogenesis. This mechanism gives rise to extensive branching evolution and cancer clone mixing, as exemplified by the coexistence of multiple cancer lineages harboring distinct ERG fusions within a single cancer nodule. Subsets of mutations were shared either by morphologically normal and malignant tissues or between different ERG lineages, indicating earlier or separate clonal cell expansions. Our observations inform on the origin of multifocal disease and have implications for prostate cancer therapy in individual cases.

1 December 2005 in The American Journal of Clinical Nutrition
Verified
Journal Article
Open access
PDF file
AGAmy V Gasper
Amy V Gasper
AAAhmed Al-Janobi
Ahmed Al-Janobi
JSJulie A Smith
Julie A Smith
JBJames R Bacon
James R Bacon
PFPaul Fortun
Paul Fortun
RMRichard Mitten
Richard Mitten
Background: Broccoli consumption is associated with a reduction in the risk of cancer, particularly in persons with a functional glutathione S-transferase M1 allele, as opposed rotrose whose GSTM1 gene has been deleted. Sulforaphane, the major isothiocyanate derived from 4-methylsulfinylbutyl glucosinolate, is thought to be the main agent conferring protection. Objective: We compared sulforaphane metabolism in GSTM1-null and GSTM1-positive subjects after they consumed standard broccoli and high-glucosinolate broccoli (super broccoli). Design: Sixteen subjects were recruited into a randomized, 3-phase crossover dietary trial of standard broccoli, super broccoli, and water. Liquid chromatography linked to tandem mass spectrometry was used to quantify sulforaphane and its thiol conjugates in plasma and urine. Results:GSTM1-null subjects had slightly higher, but statistically significant, areas under the curve for sulforaphane metabolite concentrations in plasma, a greater rate of urinary excretion of sulforaphane metabolites during the first 6 h after broccoli consumption, and a higher percentage of sulforaphane excretion 24 h after ingestion than did GSTM1-positive subjects. Consumption of high-glucosinolate broccoli led to a 3-fold greater increase in the areas under the curve and maximum concentrations of sulforaphane metabolites in plasma, a greater rate of urinary excretion of sulforaphane metabolites during the first 6 h after consumption, and a lower percentage of sulforaphane excretion after its ingestion than did the consumption of standard broccoli. Conclusions:GSTM1 genotypes have a significant effect on the metabolism of sulforaphane derived from standard or high-glucosinolate broccoli. It is possible that the difference in metabolism may explain the greater protection that GSTM1-positive persons gain from consuming broccoli. The potential consequences of consuming glucosinolate-enriched broccoli for GSTM1-null and -positive persons are discussed.


1 February 2003 in Theoretical and Applied Genetics
Verified
Journal Article
Closed access
PDF file
RMRichard Mitten
Richard Mitten
KFK. Faulkner
K. Faulkner
RMR. Magrath
R. Magrath
PRP. Rose
P. Rose
GWGary Williamson
Gary Williamson
JMJ. Marquez
J. Marquez